Circulating IgG and IgM antibodies against these peptides were also detected in patients with ANCA associated vasculitis (AASV) (67.4%(29/43)-IgG and 23.3%(10/43)-IgM, respectively) (Table 4). This evidence concerns the gene CD40LG and anti-neutrophil cytoplasmic antibody-associated vasculitis.